Análise do polimorfismo do gene p53 (códon 72) em pacientes sintomáticos para aterosclerose

Abstract

Atherosclerosis is a multifactorial pathological disease that alter the morphology and function of arterial walls. The atheroma growth leads to vessel hardening and lumen narrowing, limiting the blood flow. The atheroma plaque can eventually break, exposing highly thrombogenic material and leading to platelet activation and subsequent formation of thrombus that may block blood flow in loco, or even leading to obstruction of other vessels with a smaller diameter. This process is one of the main determinants of the clinical manifestations of atherosclerosis such as coronary artery disease (CAD), ischemic stroke, and peripheral arterial disease. Although the inflammatory theory about atherosclerosis is the most renowned one, observations point to common biological characteristics between cancer and atherosclerosis suggesting a possible association between p53 and atherosclerotic diseases. We collected peripheral blood samples from 200 individuals with clinical manifestations of atherosclerotic disease and 100 individuals without manisfestation of the disease to form the control group. DNA was subjected to molecular analysis (PCR) in order to identify the polymorphism of the p53 gene. We have not find any relationship between the polymorphism of the p53 gene and atherosclerosis in the population studied (p=0.36). There was no relationship among AD, polymorphism of the p53 gene and variants studied: gender (p = 0.78 male and 0.37 female), smoking (p = 0.72, 0.51 and 0.62 for smokers, (P = 0.17 for alcoholic and 0.38 for non-alcoholic), systemic arterial hypertension (p = 0.60), diabetes mellitus (p = 0.34), and dyslipidemia (p = 0.34). = 0.89). Our population has a high rate of miscegenation and heterozygotes and, according to studies, the arginine variant is more related to plaque formation because it induces apoptosis more frequently when compared to the proline variant. According to our results there is no association between the polymorphism of the p53 gene, atherosclerosis and its risk factors in the population studied.